dabrafenib/trametinib

1 treatment and condition followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

dabrafenib/trametinib
Treatment and conditionWhere it standsTrials
dabrafenib/trametinib for thyroid carcinoma, anaplasticPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1